CClinicalTrials.gg
CompletedNCT04454671Updated Jun 3, 2024

Ultrasound-guided Percutaneous Neuromodulation Versus Dry Needling in Shoulder Pain Treatment

An interventional study of Ultrasound-guided percutaneous neuromodulation (NMPE) and Ultrasound-guided dry needling in Shoulder Pain, sponsored by University of Alcala. Completed at 2 sites in Spain. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2024-06-03.

Sponsored by University of Alcala · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
62
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Background: nonspecific shoulder pain is very common and the symptoms can persist for 6 to 12 months in half of patients. Ultrasound-guided Percutaneous Neuromodulation (US-guided PNM) is an intervention based in an electrical stimulation of a peripheral nerve through a needle located close to the target nerve by the use of an ultrasound guidance.

Objectives: the primary aim is to determine changes in strength after US-guided PNM or Ultrasound-guided Dry Needling (US-guided DN) intervention in the Suprascapular Nerve (SN) as well as its effectiveness in changes of muscle function, pain and disability.

Methods: randomised clinical trial (ratio 1:1), single-blind (examiners), parallel, with assessment of third parties. 62 adult participants with unilateral mechanical chronic nonspecific shoulder pain with at least 3-month evolution and shoulder muscle weakness will randomised to one of two procedures: US-guided PNM or US-guided DN. It will be assessed muscle strength, muscle function, pain and disability before, just after, a week and a month after the intervention.

Read the detailed description

Shoulder pain is the third reason for medical consultation in the world. Many treatment techniques have been proposed. Neuromodulation techniques through the application of an analgesic electric current using a needle as an electrode, are increasingly used in the treatment of pain.

In this study, the investigators will compare whether the application of a neuromodulation technique is more effective than applying the dry needling technique in isolation.

02

Conditions studied

  • Shoulder Pain

Browse trials for

Keywords

  • Electric Stimulation Therapy
  • Dry Needling
03

In context

Shoulder Pain

707 studies on the registry are indexed under Shoulder Pain; 152 are open to participants now.

This study's enrollment of 62 is close to the median of 60 across 561 interventional studies indexed under Shoulder Pain.

Browse Shoulder Pain studies →

Lead sponsor

University of Alcala is the lead sponsor of 123 studies on the registry; 36 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Chronic mechanical unilateral shoulder pain of non-specific origin of at least 3 months of evolution
  • Weakness in the abduction force and / or external rotation of the shoulder.

Exclusion criteria

Exclusion Criteria:

  • Previous shoulder surgery.
  • Previous history of shoulder dislocation
  • Whiplash.
  • Cervical radiculopathy.
  • Total rupture of the rotator cuff.
  • Adhesive capsulitis.
  • Fibromyalgia diagnosis.
  • Diabetes.
  • Needle phobia or some contraindication for dry needling (anticoagulants or psychiatric disorders).
  • Bilateral shoulder pain.
  • Pregnancy or having received a dry puncture in the shoulder region in the last 6 months
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
62 participants (actual)

Study arms

  • Experimental
    ultrasound-guided percutaneous neuromodulation

    Technique based on electrical stimulation of a peripheral nerve through an ultrasound-guided needle or a muscle at a motor point. The stimulation is performed with low or medium frequency currents in which a sensory and / or motor response is sought by stimulating the peripheral nerve

    Other: Ultrasound-guided percutaneous neuromodulation (NMPE)

  • Placebo comparator
    Ultrasound-guided dry needling

    Dry needling technique applied by ultrasound-guided but without electrical stimulation of a peripheral nerve.

    Other: Ultrasound-guided dry needling

Interventions

  • OtherUltrasound-guided percutaneous neuromodulation (NMPE)

    It is a technique based on electrical stimulation of a peripheral nerve through an ultrasound-guided needle or a muscle at a motor site. The stimulation is performed with low or medium frequency currents in which a sensory and / or motor response is sought by stimulating the peripheral nerve

  • OtherUltrasound-guided dry needling

    Dry needling technique under ultrasound imaging in order to ensure accurate placement of the needle for optimum results.

06

What researchers measure

Primary outcomes

  1. Muscle Force

    Force will be measured by a manual dynamometer (microFET®2, Hoggan Scientific LLC). Measurements will be taken in Newtons (N). It will be evaluated in the movements of external rotation and abduction of both shoulders. Manual dynamometry has proven to be a tool with excellent intra-examiner reliability to assess isometric force in external rotation of the shoulder, with an intraclass correlation coefficient (ICC) of 0.96 (0.93-0.98). The minimum value is 0 and de Maximum values is 55

    Time frame: Change from Baseline force at 6 month

Secondary outcomes

  1. Shoulder Pain

    Pain intensity will be measured using the Visual Analog Scale (VAS) for pain. The VAS is a 100-mm line, oriented horizontally, with one end representing "no pain" and ten the other end representing "worst pain." Subjects will be asked to rate their current pain with a mark on the scale.

    Time frame: Change from Baseline pain at 6 month.

  2. Disability

    Disability will be measured by Shoulder Pain and Disability Index (SPADI).The Spanish version of SPADI has high test-retest reliability (ICC 0.89-0.93).The clinically important minimum difference varies between 8 and 13.2. The minimum value is 0 and de maximum value is 100

    Time frame: Change from Baseline disability at 6 month.

  3. Muscle function

    Muscle function will be measured by an ultrasound scanner (VINNO® E35; VINNO ULTRASOUND S.L.U. ©, Barcelona, Spain) with a linear transducer with a frequency range of 6-16MHz (X6-16L, 5cm footprint) will be used. The unit of measurement used will be millimeters. Muscle thickness at rest and contraction will be measured. On the other hand, the percentage of change in thickness will be measured using the equation (Shrinkage thickness - Rest thickness) \* 100 / Rest thickness.

    Time frame: Change from Baseline muscle function at 6 month.

07

Study locations

2 sites
  • Institut Physiotherapy AND pain
    Alcalá De Henares, Madrid 28805, Spain
  • Overall Study Officials
    Alcalá de Henares, Madrid 28807, Spain
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 3, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04454671
Lead sponsor
University of Alcala
Responsible party
Prof. Dr. Daniel Pecos Martín (Clinical professor, University of Alcala) — Principal investigator
First posted
Jul 1, 2020
Start date
Sep 5, 2020
Primary completion
May 31, 2024
Completion
May 31, 2024
Last update
Jun 3, 2024

Study contacts

Tomas Gallego-Izquierdo, PhD
study chair · Alcala University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion